Search for a report

NORTH AMERICA AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

NORTH AMERICA AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

The North America amniotic membrane market is expected to record a CAGR of 6.83% during the forecast period, 2022-2030, reaching a revenue share of $962.07 million by 2030.

NORTH AMERICA AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

North America Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane) Market by Application (Surgical Wounds, Ophthalmology, Other Applications) Market by End-users (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories) by Geography

Request free sample

The North America amniotic membrane market is expected to record a CAGR of 6.83% during the forecast period, 2022-2030, reaching a revenue share of $962.07 million by 2030.

The key growth drivers of the region are significant demands for amniotic membrane, given the rising techniques in the sports industry and the need for time-saving, efficient cures. At the same time, high treatment and surgery costs hinder the market growth.

North America Amniotic Membrane Market

To know more about this report, request a free sample copy

The North America amniotic membrane market growth evaluation includes the assessment of the United States and Canada. Amniotic Membrane (AM) has various biological and antimicrobial properties in corneal surgeries. It reinforces the adhesion of basal epithelial cells, modulates the proliferation of normal corneal, maintains epithelial phenotype, and enhances epithelialization. Additionally, the advantages of amniotic membranes, like their pain-reducing properties, are resulting in increased adoption of tissue-based products in ophthalmology and surgical wounds.

In the United States, the rising awareness about alternative technologies, the presence of well-established healthcare infrastructure, and the increasing healthcare expenditure propel market growth. Also, the vast use of amniotic membranes for eye surface disorders has led to their increased adoption in ophthalmic surgeries. In this regard, the growing aging population contributes to the surging number of ophthalmic surgeries in the US, thereby offering growth opportunities.

Further, the application of human AM has a wide indication spectrum in treating ocular surface disorders, as per the USA National Library of Medicine. In addition, AM transplantation has been routinely incorporated as part of ocular surface reconstruction in varied ocular pathologies.

Besides, the human AM application can be merged with all limbal transplantation types to treat stem cell deficiency (LSCD). Moreover, the growing glaucoma patient pool benefits market growth. This is because such tissue-based products are used to treat ocular surface diseases and leaking glaucoma filtering blebs with regard to glaucoma.

The segmentation analysis of the North America amniotic membrane market includes product, application, and end-users.End-Users are further sub-segmented into ambulatory surgical centers, specialized clinics, hospitals, and research centers & laboratories. Hospitals have a major role in the amniotic membrane market. This is because all the treatments, surgeries, and research are conducted in hospitals. In particular, ophthalmology, wherein treatments are administered for conjunctival reconstruction, corneal disorders with limbal stem cell deficiency, glaucoma, pterygium, etc.

On the other hand, specialized clinics are associated with a cross-subsidization/huge-volume model to sustain the large patient demand and medical needs of the underserved in the areas of kidney care, dentistry, reproductive health, and eye care. Since AM is an emerging treatment technique for swift wound healing and easy operating on eye damage, specialized clinics have become an indispensable part of AM market.

Some of the prominent market players in the North America amniotic membrane market include Katena Products Inc, Amino Technology Llc, MiMedx, etc.

MiMedx is an advanced wound care and biologics company that develops and distributes placental tissue allografts. It provides products in dental, ophthalmic, sports medicine, spine, orthopedic, surgical, burns, and wound care sectors. Its products are used in surgical applications, including plastic surgery, extremity repair, multiple orthopedic repairs and reconstructions, and vascular energy. The company has two main distribution channels, distributors and direct to customers, with headquarters in Marietta, Georgia.

One of its biomaterial platform technologies, AMNIOFIX, is a dehydrated human amnion/chorion membrane allograft. It is available in the wrap, fenestrated, and sheet configurations in various sizes to minimize wastage. Besides, it is derived from donated C-sections of live births in the US.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue (Million)
Segments Analyzed Product, Applications, End-Users
Countries Analyzed North America and Canada
Companies Analyzed Amino Technology Llc, Amino X Medical Inc, Bio-Tissue Inc, Celularity Inc, Human Regenerative Technologies, Integra LifeSciences Corp, Katena Products Inc, Labtician Ophthalmics Inc, MiMedx, Organogenesis Inc, Skye Biologics Llc, Smith & Nephew Plc, Stryker Corporation, Surgenex Llc, and SurgiLogix Llc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING INCIDENTS OF BURN INJURIES AND TRAUMATIC WOUNDS
        • INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
        • AWARENESS PROGRAMS FOR WOUND CARE TREATMENT
      • KEY RESTRAINTS
        • LIMITATIONS ASSOCIATED WITH USE OF AMNIOTIC MEMBRANE
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • CRYOPRESERVED AMNIOTIC MEMBRANE
      • LYOPHILIZATION AMNIOTIC MEMBRANE
    3. MARKET BY APPLICATION
      • SURGICAL WOUNDS
      • OPHTHALMOLOGY
      • OTHER APPLICATIONS
    4. MARKET BY END-USERS
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
      • SPECIALIZED CLINICS
      • RESEARCH CENTERS & LABORATORIES
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • AMINO TECHNOLOGY LLC
        • AMINO X MEDICAL INC
        • BIO-TISSUE INC
        • CELULARITY INC
        • HUMAN REGENERATIVE TECHNOLOGIES
        • INTEGRA LIFESCIENCES CORP
        • KATENA PRODUCTS INC
        • LABTICIAN OPHTHALMICS INC
        • MIMEDX
        • ORGANOGENESIS INC
        • SKYE BIOLOGICS LLC
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • SURGENEX LLC
        • SURGILOGIX LLC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – AMNIOTIC MEMBRANE

    TABLE 2: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 4: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 6: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY END-USERS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY END-USERS, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 8: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA AMNIOTIC MEMBRANE MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS                                                 

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

    FIGURE 6: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2022-2030 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZATION AMNIOTIC MEMBRANE, 2022-2030 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 9: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY SURGICAL WOUNDS, 2022-2030 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2022-2030 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY END-USERS, IN 2021

    FIGURE 13: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2022-2030 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTERS & LABORATORIES, 2022-2030 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 18: UNITED STATES AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 19: CANADA AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY PRODUCT
      • CRYOPRESERVED AMNIOTIC MEMBRANE
      • LYOPHILIZATION AMNIOTIC MEMBRANE
    2. MARKET BY APPLICATION
      • SURGICAL WOUNDS
      • OPHTHALMOLOGY
      • OTHER APPLICATIONS
    3. MARKET BY END-USERS
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
      • SPECIALIZED CLINICS
      • RESEARCH CENTERS & LABORATORIES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now